{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:06:02Z","timestamp":1779375962331,"version":"3.53.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":234,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n The safety of oral cannabidiol (CBD) and cannabidiolic acid (CBDA)-rich hemp oil supplementation in dogs with cancer receiving chemotherapy has not been investigated.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To evaluate the safety, tolerability, and influence on doxorubicin exposure over time of oral CBD\/CBDA-rich hemp oil supplementation in dogs diagnosed with high grade lymphoma undergoing CHOP chemotherapy.<\/jats:p>\n <\/jats:sec>\n \n Animals<\/jats:title>\n Client-owned dogs diagnosed with lymphoma.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Dogs were enrolled in this prospective, double-blinded, randomized, placebo-controlled clinical trial to receive either CBD\/CBDA-rich hemp oil capsules or placebo during one cycle of CHOP chemotherapy. Primary outcomes evaluated included adverse events during chemotherapy, quality of life scores and doxorubicin area under the curve (AUC) over a 5-week period.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Twenty-five dogs were enrolled, with 19 completing the trial. CBD\/CBDA supplementation did not significantly affect doxorubicin AUC in the intervention group. The doxorubicin AUC was not different between groups at week 0 [placebo 390.8\u2009nM\/h (318.6\u2013479.4); CBD\/CBDA 403.4\u2009nM\/h (351.9\u2013462.5)] but was different at week 5 [placebo 572.6 (448.3\u2013731.2); CBD\/CBDA 406.8 (3.23.2\u2013551.8)]. CBD\/CBDA supplementation was well-tolerated, and no serious adverse events were observed. No significant differences between groups were observed in hematological and biochemical variables. The mean (range) quality of life scores for placebo and CBD were 7.56 (0, 35), and 10.75 (0, 56), respectively, with no significant differences.<\/jats:p>\n <\/jats:sec>\n \n Conclusion and Clinical Importance<\/jats:title>\n Short-term oral CBD\/CBDA-rich hemp supplementation appeared safe and well-tolerated in dogs undergoing CHOP chemotherapy for lymphoma.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/jvim.70179","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T11:31:23Z","timestamp":1751887883000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety, Efficacy and Doxorubicin Pharmacokinetics During Cannabidiol\/Cannabidiolic Acid Rich Hemp Oil Use in Dogs With Lymphoma Undergoing CHOP Chemotherapy"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8136-9210","authenticated-orcid":false,"given":"Amandine","family":"Lejeune","sequence":"first","affiliation":[{"name":"University of California, School of Veterinary Medicine Department of Surgical and Radiological Sciences, , Davis, California,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7773-5959","authenticated-orcid":false,"given":"Sandra","family":"Bechtel","sequence":"additional","affiliation":[{"name":"University of Florida, College of Veterinary Medicine Department of Small Animal Clinical Sciences, , Gainesville, Florida,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6379-2058","authenticated-orcid":false,"given":"Rowan","family":"Milner","sequence":"additional","affiliation":[{"name":"University of Florida, College of Veterinary Medicine Department of Small Animal Clinical Sciences, , Gainesville, Florida,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Fagman","sequence":"additional","affiliation":[{"name":"University of Florida, College of Veterinary Medicine Department of Small Animal Clinical Sciences, , Gainesville, Florida,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco A.","family":"Leal Yepes","sequence":"additional","affiliation":[{"name":"Cornell University College of Veterinary Medicine Department of Population Medicine and Diagnostic Sciences, , Ithaca, New York,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Wakshlag","sequence":"additional","affiliation":[{"name":"Cornell University College of Veterinary Medicine Department of Clinical Sciences, , Ithaca, New York,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"4","key":"2026022003433803600_jvim70179-bib-0001","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/jvim.16825","article-title":"Changes in Diet and Supplement Use in Dogs With Cancer","volume":"37","author":"Kramer","year":"2023","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0002","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/vco.12599","article-title":"Unconventional Diets and Nutritional Supplements Are More Common in Dogs With Cancer Compared to Healthy Dogs: An Online Global Survey of 345 Dog Owners","volume":"18","author":"Bianco","year":"2020","journal-title":"Veterinary and Comparative Oncology"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0003","first-page":"749","article-title":"Canadian Dog Owners' Use and Perceptions of Cannabis Products","volume":"60","author":"Kogan","year":"2019","journal-title":"Canadian Veterinary Journal"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0004","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/jvim.16912","article-title":"The Efficacy and Safety of Cannabidiol as Adjunct Treatment for Drug-Resistant Idiopathic Epilepsy in 51 Dogs: A Double-Blinded Crossover Study","volume":"37","author":"Rozental","year":"2023","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"2026022003433803600_jvim70179-bib-0005","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1248417","article-title":"Efficacy and Safety of Cannabidiol for the Treatment of Canine Osteoarthritis: A Systematic Review and Meta-Analysis of Animal Intervention Studies","volume":"10","author":"Patikorn","year":"2023","journal-title":"Frontiers in Veterinary Science"},{"key":"2026022003433803600_jvim70179-bib-0006","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.939966","article-title":"Safety and Efficacy of Cannabidiol-Cannabidiolic Acid Rich Hemp Extract in the Treatment of Refractory Epileptic Seizures in Dogs","volume":"9","author":"Garcia","year":"2022","journal-title":"Frontiers in Veterinary Science"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0007","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/vco.12669","article-title":"The Effect of Cannabidiol on Canine Neoplastic Cell Proliferation and Mitogen-Activated Protein Kinase Activation During Autophagy and Apoptosis","volume":"19","author":"Henry","year":"2021","journal-title":"Veterinary and Comparative Oncology"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jvp.13403","article-title":"Cannabidiol and Cannabidiolic Acid: Preliminary In\u00a0Vitro Evaluation of Metabolism and Drug-Drug Interactions Involving Canine Cytochrome P-450, UDP-Glucuronosyltransferase, and P-Glycoprotein","volume":"47","author":"Court","year":"2024","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"key":"2026022003433803600_jvim70179-bib-0009","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1279926","article-title":"Cannabidiol Plasma Determination and Pharmacokinetics Conducted at Beginning, Middle and End of Long-Term Supplementation of a Broad-Spectrum Hemp Oil to Healthy Adult Dogs","volume":"10","author":"Corsato Alvarenga","year":"2023","journal-title":"Frontiers in Veterinary Science"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-animal-081122-070236","article-title":"Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases","volume":"11","author":"Corsato Alvarenga","year":"2023","journal-title":"Annual Review of Animal Biosciences"},{"key":"2026022003433803600_jvim70179-bib-0011","first-page":"53","volume-title":"TNM Classification of Tumours in Domestic Animals","author":"Owen","year":"1980","edition":"1st ed."},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0012","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2460\/javma.251.12.1405","article-title":"Psychometric Properties of the Canine Symptom Assessment Scale, A Multidimensional Owner-Reported Questionnaire Instrument for Assessment of Physical Symptoms in Dogs With Solid Tumors","volume":"251","author":"Giuffrida","year":"2017","journal-title":"Journal of the American Veterinary Medical Association"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0013","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1476-5829.2009.00200.x","article-title":"Response Evaluation Criteria for Peripheral Nodal Lymphoma in Dogs (v1.0)\u2014A Veterinary Cooperative Oncology Group (VCOG) Consensus Document","volume":"8","author":"Vail","year":"2010","journal-title":"Veterinary and Comparative Oncology"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0014","first-page":"311","article-title":"Veterinary Cooperative Oncology Group\u2014Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) Following Investigational Therapy in Dogs and Cats","volume":"19","author":"Ak","year":"2021","journal-title":"Veterinary and Comparative Oncology"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1476-5829.2012.00340.x","article-title":"Development of a Limited-Sampling Model for Prediction of Doxorubicin Exposure in Dogs","volume":"12","author":"Wittenburg","year":"2014","journal-title":"Veterinary and Comparative Oncology"},{"key":"2026022003433803600_jvim70179-bib-0016","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fvets.2020.00505","article-title":"Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, \u03949-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract","volume":"7","author":"Wakshlag","year":"2020","journal-title":"Frontiers in Veterinary Science"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0017","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jvp.12896","article-title":"Serum Cannabidiol, Tetrahydrocannabinol (THC), and Their Native Acid Derivatives After Transdermal Application of a Low-THC Cannabis Sativa Extract in Beagles","volume":"43","author":"Hannon","year":"2020","journal-title":"Journal of Veterinary Pharmacology and Therapeutics"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0018","doi-asserted-by":"crossref","DOI":"10.1111\/vde.13077","article-title":"The Effect of a Mixed Cannabidiol and Cannabidiolic Acid Based Oil on Client-Owned Dogs With Atopic Dermatitis","volume":"33","author":"Loewinger","year":"2022","journal-title":"Veterinary Dermatology"},{"key":"2026022003433803600_jvim70179-bib-0019","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rvsc.2018.12.003","article-title":"Pharmacokinetics of Bedrocan, a Cannabis Oil Extract, in Fasting and Fed Dogs: An Explorative Study","volume":"123","author":"\u0141ebkowska-Wieruszewska","year":"2019","journal-title":"Research in Veterinary Science"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0020","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2460\/ajvr.82.5.405","article-title":"Randomized, Placebo-Controlled, 28-Day Safety and Pharmacokinetics Evaluation of Repeated Oral Cannabidiol Administration in Healthy Dogs","volume":"82","author":"Vaughn","year":"2021","journal-title":"American Journal of Veterinary Research"},{"key":"2026022003433803600_jvim70179-bib-0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fvets.2020.00051","article-title":"Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs","volume":"7","author":"Vaughn","year":"2020","journal-title":"Frontiers in Veterinary Science"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0022","first-page":"178","article-title":"Pharmacokinetics of Cannabidiol Administered by 3 Delivery Methods at 2 Different Dosages to Healthy Dogs","volume":"82","author":"Bartner","year":"2018","journal-title":"Canadian Journal of Veterinary Research"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0023","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/ani9100832","article-title":"Single-Dose Pharmacokinetics and Preliminary Safety Assessment With Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats","volume":"9","author":"Deabold","year":"2019","journal-title":"Animals"},{"key":"2026022003433803600_jvim70179-bib-0024","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.977457","article-title":"Long-Term Daily Feeding of Cannabidiol Is Well-Tolerated by Healthy Dogs","volume":"9","author":"Bradley","year":"2022","journal-title":"Frontiers in Veterinary Science"},{"key":"2026022003433803600_jvim70179-bib-0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fvets.2018.00165","article-title":"Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs","volume":"5","author":"Gamble","year":"2018","journal-title":"Frontiers in Veterinary Science"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0026","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a Potential Treatment for Anxiety Disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0027","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/ani13020245","article-title":"Evaluation of an Oral Supplemental Cannabidiol Product for Acceptability and Performance in Mature Horses","volume":"13","author":"Leise","year":"2023","journal-title":"Animals (Basel)"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0028","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2460\/javma.233.1.104","article-title":"Perceptions and Priorities of Owners of Dogs With Heart Disease Regarding Quality Versus Quantity of Life for Their Pets","volume":"233","author":"Oyama","year":"2008","journal-title":"Journal of the American Veterinary Medical Association"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0029","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1939-1676.2010.0583.x","article-title":"Perceptions of Quality of Life and Priorities of Owners of Cats With Heart Disease","volume":"24","author":"Reynolds","year":"2010","journal-title":"Journal of Veterinary Internal Medicine"},{"issue":"4","key":"2026022003433803600_jvim70179-bib-0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5326\/JAAHA-MS-7119","article-title":"Evaluation of the Effect of Cannabidiol on Naturally Occurring Osteoarthritis-Associated Pain: A Pilot Study in Dogs","volume":"57","author":"Mejia","year":"2021","journal-title":"Journal of the American Animal Hospital Association"},{"key":"2026022003433803600_jvim70179-bib-0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fvets.2020.583404","article-title":"Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs","volume":"7","author":"Chicoine","year":"2020","journal-title":"Frontiers in Veterinary Science"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/39\/4\/jvim70179\/67010931\/jvim70179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/39\/4\/jvim70179\/67010931\/jvim70179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:43:49Z","timestamp":1771577029000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/doi\/10.1111\/jvim.70179\/8492795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.70179","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"2024-09-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jvim70179"}}